Kevin Ali - Mar 31, 2024 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Executive Officer, Director
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Stock symbol
OGN
Transactions as of
Mar 31, 2024
Transactions value $
-$628,428
Form type
4
Date filed
4/3/2024, 06:41 PM
Previous filing
Apr 2, 2024
Next filing
May 7, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OGN Common Stock Options Exercise $0 +21.5K +21.84% $0.00 120K Mar 31, 2024 Direct
transaction OGN Common Stock Tax liability -$223K -11.9K -9.91% $18.80 108K Mar 31, 2024 Direct
transaction OGN Common Stock Options Exercise $0 +39K +36.11% $0.00 147K Mar 31, 2024 Direct
transaction OGN Common Stock Tax liability -$405K -21.6K -14.67% $18.80 125K Mar 31, 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Options Exercise $0 -21.5K -50% $0.00 21.5K Mar 31, 2024 Common Stock 21.5K Direct F1, F2
transaction OGN Restricted Stock Units Options Exercise $0 -39K -33.33% $0.00 77.9K Mar 31, 2024 Common Stock 39K Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit converts into one share of Organon & Co. ("Organon") common stock.
F2 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon common stock for each RSU. On each of March 31, 2023, and March 31, 2024, one-third of the RSUs vested, with the remaining RSUs to vest on March 31, 2025.
F3 On March 31, 2024, one-third of the RSUs vested with the remaining RSUs to vest in two equal installments on March 31, 2025 and March 31, 2026.